29.75
price up icon2.37%   0.69
after-market アフターアワーズ: 29.75
loading
前日終値:
$29.06
開ける:
$29.26
24時間の取引高:
1.39M
Relative Volume:
0.80
時価総額:
$4.91B
収益:
$1.51B
当期純損益:
$333.35M
株価収益率:
15.26
EPS:
1.95
ネットキャッシュフロー:
$315.22M
1週間 パフォーマンス:
+2.41%
1か月 パフォーマンス:
+10.06%
6か月 パフォーマンス:
-15.77%
1年 パフォーマンス:
+6.29%
1日の値動き範囲:
Value
$29.14
$29.96
1週間の範囲:
Value
$28.10
$29.96
52週間の値動き範囲:
Value
$25.56
$36.45

Alkermes Plc Stock (ALKS) Company Profile

Name
名前
Alkermes Plc
Name
セクター
Healthcare (1157)
Name
電話
00-353-1-772-8000
Name
住所
CONNAUGHT HOUSE, DUBLIN 4
Name
職員
1,800
Name
Twitter
@alkermes
Name
次回の収益日
2024-10-24
Name
最新のSEC提出書
Name
ALKS's Discussions on Twitter

ALKS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
ALKS
Alkermes Plc
29.75 4.64B 1.51B 333.35M 315.22M 1.95
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
156.62 67.51B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.52 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.82 43.42B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.46 20.72B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
312.23 14.21B 2.99B 1.21B 1.13B 25.06

Alkermes Plc Stock (ALKS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-15 開始されました Goldman Buy
2025-06-17 アップグレード UBS Neutral → Buy
2025-05-28 開始されました Needham Buy
2025-03-13 開始されました RBC Capital Mkts Sector Perform
2025-03-04 アップグレード UBS Sell → Neutral
2025-02-11 開始されました Deutsche Bank Buy
2024-11-05 アップグレード Stifel Hold → Buy
2024-06-17 開始されました TD Cowen Buy
2024-03-19 開始されました Robert W. Baird Outperform
2024-02-20 ダウングレード UBS Neutral → Sell
2023-11-20 再開されました JP Morgan Neutral
2023-10-24 アップグレード Evercore ISI In-line → Outperform
2023-10-17 開始されました UBS Neutral
2022-11-03 アップグレード Piper Sandler Neutral → Overweight
2022-10-14 アップグレード BofA Securities Underperform → Neutral
2022-08-16 開始されました Piper Sandler Neutral
2022-04-22 再開されました Goldman Buy
2022-04-20 開始されました Goldman Buy
2022-01-27 アップグレード Cantor Fitzgerald Hold → Overweight
2021-12-01 開始されました Citigroup Neutral
2021-10-07 アップグレード Jefferies Hold → Buy
2021-09-02 ダウングレード BofA Securities Neutral → Underperform
2020-10-15 アップグレード Mizuho Neutral → Buy
2020-07-30 ダウングレード Goldman Neutral → Sell
2020-02-14 ダウングレード BofA/Merrill Buy → Neutral
2020-02-14 繰り返されました H.C. Wainwright Neutral
2020-02-14 ダウングレード JP Morgan Overweight → Neutral
2020-02-06 開始されました Mizuho Neutral
2020-01-31 アップグレード Wolfe Research Underperform → Peer Perform
2019-09-05 アップグレード Morgan Stanley Underweight → Equal-Weight
2019-07-15 アップグレード Goldman Sell → Neutral
2019-05-31 開始されました H.C. Wainwright Neutral
2019-05-01 ダウングレード Citigroup Buy → Neutral
2018-12-19 ダウングレード Goldman Neutral → Sell
2018-12-14 開始されました Wolfe Research Underperform
2018-12-13 ダウングレード Credit Suisse Outperform → Underperform
2018-11-05 開始されました Piper Jaffray Neutral
2018-08-07 開始されました Stifel Hold
2018-06-21 ダウングレード Morgan Stanley Equal-Weight → Underweight
2018-06-06 開始されました B. Riley FBR, Inc. Buy
2018-05-16 アップグレード Citigroup Neutral → Buy
2018-05-11 開始されました BofA/Merrill Buy
すべてを表示

Alkermes Plc (ALKS) 最新ニュース

pulisher
Aug 20, 2025

After culling 90% of staff, Waltham biotech finds buyer - NBC Boston

Aug 20, 2025
pulisher
Aug 20, 2025

Opioid Use Disorder Market: Generated Opportunities and Future Scope by 2032 | Indivior PLC, Alkermes, Orexo AB - openPR.com

Aug 20, 2025
pulisher
Aug 18, 2025

Chart Analysts Warn of Resistance Near Alkermes plc PriceWeekly Market Outlook & Community Driven Trade Alerts - kangso.co.kr

Aug 18, 2025
pulisher
Aug 18, 2025

Will Lowered Earnings Forecasts Shift Alkermes' (ALKS) Valuation Story or Reinforce Investor Caution? - simplywall.st

Aug 18, 2025
pulisher
Aug 17, 2025

Price Floor Holding on Alkermes plc — Rebound PossibleQuarterly Portfolio Review & Daily Profit Maximizing Trade Tips - 선데이타임즈

Aug 17, 2025
pulisher
Aug 16, 2025

Visual analytics tools that track Alkermes plc performance2025 Winners & Losers & Daily Growth Stock Investment Tips - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Visual trend scoring systems applied to Alkermes plcJuly 2025 Update & Weekly Stock Breakout Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Intraday pattern recognizer results for Alkermes plcJuly 2025 Summary & Stock Timing and Entry Methods - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

What’s the recovery path for long term holders of Alkermes plcGap Down & Safe Entry Point Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Investors Don't See Light At End Of Alkermes Plc's (NASDAQ:ALKS) Tunnel - 富途牛牛

Aug 15, 2025
pulisher
Aug 15, 2025

Is Alkermes plc stock influenced by commodity prices2025 Trading Volume Trends & Pattern Based Trade Signal System - thegnnews.com

Aug 15, 2025
pulisher
Aug 15, 2025

Charles Schwab Investment Management Inc. Sells 21,558 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World

Aug 15, 2025
pulisher
Aug 15, 2025

PNC Financial Services Group Inc. Has $408,000 Stock Holdings in Alkermes plc (NASDAQ:ALKS) - Defense World

Aug 15, 2025
pulisher
Aug 14, 2025

Vanguard Group Inc. Sells 283,511 Shares of Alkermes plc (NASDAQ:ALKS) - Defense World

Aug 14, 2025
pulisher
Aug 12, 2025

Live Scanner Shows Breakout on Alkermes plcMarket Surge Signal for Swing Traders Triggered - metal.it

Aug 12, 2025
pulisher
Aug 10, 2025

Is Alkermes plc in a long term uptrendWealth Leverage Stock List - mustnews.co.kr

Aug 10, 2025
pulisher
Aug 09, 2025

Avantax Advisory Services Inc. Makes New $246,000 Investment in Alkermes plc (NASDAQ:ALKS) - Defense World

Aug 09, 2025
pulisher
Aug 08, 2025

BlackRock increases stake in Alkermes to 17% - Investing.com India

Aug 08, 2025
pulisher
Aug 08, 2025

BlackRock increases stake in Alkermes to 17% By Investing.com - Investing.com Nigeria

Aug 08, 2025
pulisher
Aug 07, 2025

Alkermes plc Ireland - AD HOC NEWS

Aug 07, 2025
pulisher
Aug 04, 2025

Alkermes plc Included in Top Momentum ScanInvestment Strategy Designed for Capital Protection - metal.it

Aug 04, 2025
pulisher
Aug 04, 2025

Chondrosarcoma Market: Epidemiology, Pipeline Products, - openPR.com

Aug 04, 2025
pulisher
Aug 04, 2025

Alkermes plc Announces Pricing of New Term Loans - AOL.com

Aug 04, 2025
pulisher
Aug 04, 2025

HC Wainwright Brokers Boost Earnings Estimates for Alkermes - Defense World

Aug 04, 2025
pulisher
Aug 03, 2025

What markets is AAON Inc. expanding into Is Alkermes plc stock a good long term investment optionBuild a diversified portfolio for steady growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of Alkermes plc stockUnmatched market gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Alkermes plc a growth stock or a value stockInvest smarter with expert trading signals - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Alkermes plc stock price move sharplyInvest confidently with professional advice - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Alkermes plc stock overvalued or undervaluedGet exclusive access to expert stock recommendations - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Alkermes Q2 Earnings Beat Estimates, Proprietary Drugs Aid Sales - MSN

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Alkermes plc stock higher in 2025Invest confidently with professional advice - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Alkermes plc stock in 2025Get expert analysis on top stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Needham & Company LLC Reaffirms "Buy" Rating for Alkermes (NASDAQ:ALKS) - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

How does Alkermes plc generate profit in a changing economyBuild capital through low-risk investments - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Alkermes plc in the next 12 monthsAchieve rapid portfolio growth with expert guidance - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What are the technical indicators suggesting about Alkermes plcDiscover investment plans that deliver results - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How strong is Alkermes plc company’s balance sheetUnlock powerful portfolio optimization tools - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What markets is Alkermes plc expanding into Is ASLE stock a good long term investment optionBuild a portfolio that outperforms consistently - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Alkermes Reports Q2 2025 Financial Results, Reiterates Expectations and Highlights Positive Clinical Study Results - AInvest

Aug 02, 2025
pulisher
Aug 02, 2025

ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Alkermes plc To Contact The Firm - ACCESS Newswire

Aug 02, 2025
pulisher
Jul 31, 2025

Alkermes shares climb 5% following Q2 earnings and revenue beat - MSN

Jul 31, 2025
pulisher
Jul 31, 2025

(07/31/25) ALKS: Positive Narcolepsy Drug Trial Puts this Biotech Name in F - moneyshow.com

Jul 31, 2025
pulisher
Jul 30, 2025

Alkermes anticipates record proprietary product sales above $1B for 2025 as orexin pipeline advances - MSN

Jul 30, 2025
pulisher
Jul 30, 2025

Alkermes: A More Than Solid Quarter (NASDAQ:ALKS) - Seeking Alpha

Jul 30, 2025
pulisher
Jul 30, 2025

Alkermes stock price target raised to $42 from $40 at RBC Capital - Investing.com Nigeria

Jul 30, 2025
pulisher
Jul 30, 2025

Alkermes plc (NASDAQ:ALKS) Q2 2025 Earnings Call Transcript - Insider Monkey

Jul 30, 2025
pulisher
Jul 30, 2025

Alkermes Beat Expectations With A Strong Second Quarter - Finimize

Jul 30, 2025
pulisher
Jul 30, 2025

Schizophrenia Drugs Market Exclusive Report with Detailed - openPR.com

Jul 30, 2025
pulisher
Jul 30, 2025

Alkermes PLC (ALKS) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Jul 30, 2025
pulisher
Jul 30, 2025

Alkermes: Q2 Earnings Snapshot - Norwalk Hour

Jul 30, 2025
pulisher
Jul 29, 2025

Alkermes Reports Strong Q2 2025 Financial Results - TipRanks

Jul 29, 2025

Alkermes Plc (ALKS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Alkermes Plc (ALKS) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Nichols Christian Todd
SVP, Chief Commercial Officer
Jun 10 '25
Sale
31.09
3,334
103,654
86,208
$17.91
price up icon 2.40%
drug_manufacturers_specialty_generic RDY
$14.51
price up icon 0.62%
$10.65
price down icon 0.37%
$135.43
price up icon 0.11%
$312.23
price up icon 0.51%
大文字化:     |  ボリューム (24 時間):